RFC
ANIK icon

Regions Financial Corp’s Anika Therapeutics ANIK Stock Holding History

Regions Financial Corp’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-494
Closed -$15K – 864
2019
Q1 		$15K Hold
494
– – ﹤0.01% 1430
2018
Q4 		$17K Buy
494
+3
+0.6% +$108 ﹤0.01% 1391
2018
Q3 		$21K Hold
491
– – ﹤0.01% 1436
2018
Q2 		$16K Sell
491
-83
-14% -$3.42K ﹤0.01% 1518
2018
Q1 		$29K Sell
574
-145
-20% -$8.19K ﹤0.01% 1355
2017
Q4 		$39K Buy
+719
New +$39.8K ﹤0.01% 1308

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Regions Financial Corp's ANIK Position: Q2 2019 in Review

Regions Financial Corp sold out of Anika Therapeutics (ANIK) in Q2 2019, closing a stake of 494 shares — an estimated $15K sold.

Regions Financial Corp first reported a position in ANIK in Q4 2017 and held it in 6 quarters. The position peaked at $39K in Q4 2017. 165 funds tracked by Wall St. Rank hold ANIK as of Q2 2019.

  • Regions Financial Corp reported no remaining Anika Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Regions Financial Corp sold 494 Anika Therapeutics shares in Q2 2019, an estimated $15K.
  • Regions Financial Corp first reported a position in Anika Therapeutics in Q4 2017 and held it in 6 quarters.
  • Regions Financial Corp's Anika Therapeutics position peaked at $39K in Q4 2017.
  • 165 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.